IL6 and type 2 diabetes mellitus: For instance, a recent study that included 37 T2DM participants involved in the CAROLINA® trial revealed no association between cognitive deterioration and the markers of inflammation CRP, IL-6, and tumor necrosis factor-α (TNF-α) [147].